Summary:
- This article discusses new 4-year data on a drug called TransCon PTH, which is used to treat a condition called hypoparathyroidism.
- Hypoparathyroidism is a rare hormonal disorder where the parathyroid glands do not produce enough parathyroid hormone, leading to low calcium levels in the blood.
- The data shows that TransCon PTH was able to sustain a response in patients with hypoparathyroidism over a 4-year period, helping to maintain normal calcium levels and reduce the need for other medications.